Central precocious puberty: Treatment with triptorelin 11.25mg

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Chiocca, Elena ^a   Dati, Eleonora ^a   Baroncelli, Giampiero I ^a   Cassio, Alessandra ^b   Wasniewska, Malgorzata ^c   Galluzzi, Fiorella ^d   Einaudi, Silvia ^e   Cappa, Marco ^f   Russo, Gianni ^g   Bertelloni, Silvano ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE; TRIPTORELIN; LUTEOLYTIC AGENT;

ARTICLE; CENTRAL PRECOCIOUS PUBERTY; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; FOLLOW UP; HUMAN; MALE; PRECOCIOUS PUBERTY; SCHOOL CHILD; BLOOD; GONAD; HYPOPHYSIS; METABOLISM; TIME; TREATMENT OUTCOME;

CHILD; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; GONADS; HUMANS; LUTEINIZING HORMONE; LUTEOLYTIC AGENTS; MALE; PITUITARY GLAND; PUBERTY, PRECOCIOUS; TIME FACTORS; TREATMENT OUTCOME; TRIPTORELIN PAMOATE;

EID: 84862306045     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/583751     Document Type: Article

References (26)

1. Larsen P. R., Kronenberg H. M., Melmed S., Polansky K. S., Puberty: ontogenety, Neuroendocrinology, physiology and disorders Williams Textbook of Endocrinology 2003 10th chapter 24 Philadelphia, Pa, USA Saunders 1115 1239
2. Carel J. C., Eugster E. A., Rogol A., Ghizzoni L., Palmert M. R., Consensus statement on the use of gonadotropin-releasing hormone analogs in children Pediatrics 2009 138 752 762
3. Lahlou N., Carel J. C., Chaussain J. L., Roger M., Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics Journal of Pediatric Endocrinology and Metabolism 2000 13 supplement 1 723 737
4. Heger S., Mller M., Ranke M., Schwarz H. P., Waldhauser F., Partsch C. J., Sippell W. G., Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function Molecular and Cellular Endocrinology 2006 254-255 217 220 (Pubitemid 44041747)
5. Bouchot O., Soret J. Y., Jacqmin D., Lahlou N., Roger M., Blumberg J., Three-month sustained-release form of triptorelin in patients with advanced prostatic adenocarcinoma: results of an open pharmacodynamic and pharmacokinetic multicenter study Hormone Research 1998 50 2 89 93 (Pubitemid 28418244)
6. Carel J. C., Lahlou N., Jaramillo O., Montauban V., Teinturier C., Colle M., Lucas C., Chaussain J. L., Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25mg) Journal of Clinical Endocrinology and Metabolism 2002 87 9 4111 4116
7. Carel J. C., Blumberg J., Seymour C., Adamsbaum C., Lahlou N., Three-month sustained-release triptorelin (11.25mg) in the treatment of central precocious puberty European Journal of Endocrinology 2006 154 1 119 124 (Pubitemid 43250745)
8. Martnez-Aguayo A., Hernndez M. I., Beas F., Iiguez G., vila A., Sovino H., Bravo E., Cassorla F., Treatment of central precocious puberty with triptorelin 11.25mg depot formulation Journal of Pediatric Endocrinology and Metabolism 2006 19 8 963 970 (Pubitemid 44349728)
9. Badaru A., Wilson D. M., Bachrach L. K., Fechner P., Gandrud L. M., Durham E., Wintergerst K., Chi C., Klein K. O., Neely E. K., Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty Journal of Clinical Endocrinology and Metabolism 2006 91 5 1862 1867
10. Mericq V., Lammoglia J. J., Unanue N., Villaroel C., Hernndez M. I., vila A., Iiguez G., Klein K. O., Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results Clinical Endocrinology 2009 71 5 686 690
11. Chiocca E., Dati E., Baroncelli G. I., Mora S., Parrini D., Erba P., Bertelloni S., Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height Neuroendocrinology 2009 89 4 441 447
12. Tanner J. M., Whitehouse R. H., Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty Archives of Disease in Childhood 1976 51 3 170 179
13. Greulich W. W., Pyle S. I., Radiographic Atlas of Skeletal Development of the Hand and the Wrist 1959 2nd Stanford, Calif, USA Stanford University Press
14. Bayley N., Pinneau S. R., Tables for predicting adult height from skeletal age: revised for use with the greulich-pyle hand standards The Journal of Pediatrics 1952 40 4 423 441
15. Cole T. J., Bellizzi M. C., Flegal K. M., Dietz W. H., Establishing a standard definition for child overweight and obesity worldwide: international survey British Medical Journal 2000 320 7244 1240 1243 (Pubitemid 30240471)
16. Meriq M. C., Youlton R. Y., Willshaw Z., Efectividad de la terapia con leuprolide acetate de deposito cada tres meses en pubertad precoz central Revue de Medicine Chile 2006 134 821 826 (Pubitemid 44357836)
17. Trueman J. A., Tillmann V., Cusick C. F., Foster P., Patel L., Hall C. M., Price D. A., Clayton P. E., Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle Clinical Endocrinology 2002 57 2 223 230 (Pubitemid 34989099)
18. Isaac H., Patel L., Meyer S., Hall C. M., Cusick C., Price D. A., Clayton P. E., Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty Hormone Research 2007 68 4 157 163 (Pubitemid 350194927)
19. Lewis K. A., Eugster E. A., Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty Drug Design, Development and Therapy 2009 21 3 1 5
20. Rahhal S., Clarke W. L., Kletter G. B., Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty International Journal of Pediatric Endocrinology 2009 2009 1
21. Berges R., Bello U., Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancer Current Medical Research and Opinion 2006 22 4 649 655
22. Donnez J., Dewart P. J., Hedon B., Perino A., Schindler A. E., Blumberg J., Querleu D., Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis Fertility and Sterility 2004 81 2 297 304 (Pubitemid 38223906)
23. Fuld K., Chi C., Neely E. K., A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty Journal of Pediatrics 2011 159 6 982 987
24. Parker K. L., Baens-Bailon R. G., Lee P. A., Depot leuprolide acetate dosage for sexual precocity Journal of Clinical Endocrinology and Metabolism 1991 73 1 50 52 (Pubitemid 21901098)
25. Massart F., Federico G., Harrell J. C., Saggese G., Growth outcome during gnrh agonist treatments for slowly progressive central precocious puberty Neuroendocrinology 2009 90 3 307 314
26. Miller B. S., Shukla A. R., Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists Clinical Therapeutics 2010 32 10 1749 1751